Biobeat Technologies secures $50 million Series B financing led by Ally Bridge Group, OrbiMed Advisors, and Elevage Medical to advance its patch-worn, cuff-less blood pressure monitor.
Amount Raised
$50 Million
Round Type
Series B
Boca RatonBiotechnologyHealth CareMedicalMedical DeviceInvestors
Description
Biobeat Technologies, Ltd. has announced the closing of a $50 million Series B equity financing to help commercialize its FDA-cleared, cuff-less, 24-hour ambulatory blood pressure monitor. The financing was led by new investors including Ally Bridge Group, OrbiMed Advisors, and Elevage Medical. Proceeds will be used to expand commercialization efforts in the United States
Quick answer
Biobeat Technologies raised $50 Million in a Series B round, dated December 30, 2025. Investors: Ally Bridge Group, Orbimed Advisors and Elevage Medical. Biobeat Technologies is based in Boca Raton, Florida, United States.
- How much did Biobeat Technologies raise?
- Biobeat Technologies raised $50 Million in a Series B round on December 30, 2025.
- Who invested in Biobeat Technologies?
- Ally Bridge Group, Orbimed Advisors and Elevage Medical are named as investors in this round.
- What does Biobeat Technologies do?
- Biobeat is an innovative company with operations in Tel Aviv, Israel and Boca Raton, Florida.
- Where is Biobeat Technologies based and how big is it?
- Biobeat Technologies is based in Boca Raton, Florida, United States. Fundz records about 42 employees.
- Who are the decision-makers at Biobeat Technologies?
- Fundz holds 3 contacts at Biobeat Technologies, including the VP Business Development & Sales. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Medical and Medical Device around the same time
Companies in the same sectors as Biobeat Technologies that raised within 45 days of this round, from Fundz verified event records.
- Flyte Aviation, Inc. raised $37M (Funding Round) on February 12, 2026.
- Exact Imaging raised $10M (Funding Round) on February 10, 2026.
- Positron raised $230M (Series B) on February 4, 2026.
- QT Sense raised $4.7M (Funding Round) on February 4, 2026.
- Nami Surgical raised $2.6M (Seed) on January 28, 2026.
- Conavi Medical raised $700K (Seed) on January 13, 2026.
Who to call at Biobeat Technologies, and when
A new round usually means Biobeat Technologies is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Biobeat Technologies raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Biobeat Technologies, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Biobeat Technologies. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Biobeat Technologies raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansBiobeat Technologies raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.